Ipca Laboratories Limited
IPCALAB
Rang in Aktien
#3271
Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures... Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Aktienkurs
$21.24
Marktkapitalisierung
$5.39B
Veränderung (1 Tag)
6.09%
Veränderung (1 Jahr)
45.94%
Land
IN
Handel Ipca Laboratories Limited (IPCALAB)
Kategorie
Healthcare
Kursverlauf für Ipca Laboratories Limited (IPCALAB)
Höchster Schlusskurs: $21.08 am 2026-10-01
Niedrigster Schlusskurs: $0.09 am 1996-01-01
Niedrigster Schlusskurs: $0.09 am 1996-01-01
Kursverlauf der Aktie von Ipca Laboratories Limited von 1996 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 11.41% |
| 2025 | -13.23% |
| 2024 | 38.48% |
| 2023 | 27.11% |
| 2022 | -23.07% |
| 2021 | -9.79% |
| 2020 | 89.81% |
| 2019 | 41.72% |
| 2018 | 27.54% |
| 2017 | 9.85% |
| 2016 | -29.56% |
| 2015 | -1.24% |
| 2014 | 3.97% |
| 2013 | 24.31% |
| 2012 | 74.85% |
| 2011 | -31.23% |
| 2010 | 70.55% |
| 2009 | 196.37% |
| 2008 | -55.33% |
| 2007 | 35.03% |
| 2006 | 33.17% |
| 2005 | -5.25% |
| 2004 | 46.12% |
| 2003 | 294.98% |
| 2002 | 90.18% |
| 2001 | -30.77% |
| 2000 | -57.08% |
| 1999 | 391.04% |
| 1998 | -1.48% |
| 1997 | 26.94% |
| 1996 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $161.15 | 21.02% |
DE
|
|
| $41.46 | 47.41% |
JP
|
|
| $212.49 | 23.19% |
CH
|
|
| $19.19 | -0.09% |
IN
|
